Retreatment of advanced esthesioneuroblastoma with high-activity I-125 endocurietherapy: a case report.
A 67-year-old woman presented with an advanced esthesioneuroblastoma that recurred 2 years following external irradiation. She was successfully retreated with continuous low-dose rate interstitial irradiation from high-activity I-125 seeds implanted permanently into the tumor.
Kumar
P P
PP
Division of Radiation Oncology, University of Nebraska Medical Center, Omaha 68105-1065.
Ogren
F P
FP
McComb
R D
RD
Jones
E O
EO
McCaul
G F
GF
D000368:Aged; D001918:Brachytherapy / Q000379:methods*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage; D009296:Nasal Cavity; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D018241:Neuroectodermal Tumors, Primitive, Peripheral / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D009669:Nose Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D014057:Tomography, X-Ray Computed
D007457:Iodine Radioisotopes